Chengdu Welcomes Two Industrial Headquarters Projects: Serrano Medtech Advances Structural Heart Device Innovation

Source: Chengdu Daily Jinguang

Two Major Industrial Headquarters Projects Settle in Chengdu

Recently, Chengdu Silara Medtech Inc. officially signed an agreement to settle in Chengdu Tianfu International Bio City, planning to build its corporate headquarters, R&D center, and production base to systematically carry out the research, development, production, and sales of medical devices in the field of structural heart disease.

Silara Medtech is a high-tech enterprise focusing on the field of泛心脏病 (pan-cardiovascular diseases), dedicated to becoming the leading科技创新独角兽 (scientific and technological innovation unicorn) in China's泛心脏病 (pan-cardiovascular diseases) sector. The company has completed its global patent layout, holding 21 authorized invention patents and 19 utility model patents. It has established strong ties with top cardiac centers such as Fuwai Hospital of the Chinese Academy of Medical Sciences and Guangdong Provincial People's Hospital, creating a collaborative innovation system that bridges clinical needs with technological transformation.

After settling in BioCity, Silara Medtech will leverage its existing clinical cooperation network and R&D platform to accelerate the clinical research, registration application, and industrialization of several core products, further consolidating its leading position in the field of cardiac interventional devices.

This settlement also represents the company's high recognition of the biocity's industrial ecosystem, "which will bring a 'qualitative leap' to the structural heart disease device industry in the park." In recent years, Biocity has continued to deeply cultivate in the medical device field, including in vitro diagnostics, implantable and interventional products, and medical...Robotand other细分tracks form a strong industrial cluster effect.

Reporter Tang Xiaowei from Chengdu Daily Jin Guan News